Thursday, 9 July 2026
Deeptech startup Enlife bags Rs 6 crore to develop AI blood test for Alzheimer's
techindia
Summary
Public feed summary: Enlife raised Rs 6 crore to advance an AI-powered blood test for Alzheimer's that aims to replace more costly and invasive scans.
Why it matters
Diagnostics plus AI remains one of the clearest deeptech wedges: lower-cost testing can unlock access, but only if clinical validation keeps pace with the product story.
Founder/operator read
Health-tech founders need evidence, not just ambition. Expect investors and partners to focus on validation, regulatory path, and clinical adoption channels.